Literature DB >> 19829754

Modeling cumulative incidence function for competing risks data.

Mei-Jie Zhang1, Xu Zhang, Thomas H Scheike.   

Abstract

A frequent occurrence in medical research is that a patient is subject to different causes of failure, where each cause is known as a competing risk. The cumulative incidence curve is a proper summary curve, showing the cumulative failure rates over time due to a particular cause. A common question in medical research is to assess the covariate effects on a cumulative incidence function. The standard approach is to construct regression models for all cause-specific hazard rate functions and then model a covariate-adjusted cumulative incidence curve as a function of all cause-specific hazards for a given set of covariates. New methods have been proposed in recent years, emphasizing direct assessment of covariate effects on cumulative incidence function. Fine and Gray proposed modeling the effects of covariates on a subdistribution hazard function. A different approach is to directly model a covariate-adjusted cumulative incidence function, including a pseudovalue approach by Andersen and Klein and a direct binomial regression by Scheike, Zhang and Gerds. In this paper, we review the standard and new regression methods for modeling a cumulative incidence function, and give the sources of computer packages/programs that implement these regression models. A real bone marrow transplant data set is analyzed to illustrate various regression methods.

Entities:  

Year:  2008        PMID: 19829754      PMCID: PMC2760993          DOI: 10.1586/17512433.1.3.391

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  12 in total

Review 1.  Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.

Authors:  J P Klein; J D Rizzo; M J Zhang; N Keiding
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483

2.  Confidence bands for cumulative incidence curves under the additive risk model.

Authors:  Y Shen; S C Cheng
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

3.  SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.

Authors:  Susanne Rosthøj; Per K Andersen; Steen Z Abildstrom
Journal:  Comput Methods Programs Biomed       Date:  2004-04       Impact factor: 5.428

4.  Extensions and applications of the Cox-Aalen survival model.

Authors:  Thomas H Scheike; Mei-Jie Zhang
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

5.  Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.

Authors:  John P Klein; Per Kragh Andersen
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

6.  Modelling competing risks in cancer studies.

Authors:  John P Klein
Journal:  Stat Med       Date:  2006-03-30       Impact factor: 2.373

7.  SAS and R functions to compute pseudo-values for censored data regression.

Authors:  John P Klein; Mette Gerster; Per Kragh Andersen; Sergey Tarima; Maja Pohar Perme
Journal:  Comput Methods Programs Biomed       Date:  2008-01-15       Impact factor: 5.428

8.  Prediction of cumulative incidence function under the proportional hazards model.

Authors:  S C Cheng; J P Fine; L J Wei
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

9.  A linear regression model for the analysis of life times.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

10.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

View more
  16 in total

1.  Weighted comparison of two cumulative incidence functions with R-CIFsmry package.

Authors:  Jianing Li; Jennifer Le-Rademacher; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2014-06-11       Impact factor: 5.428

Review 2.  NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

Authors:  Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael R Bishop; Daniel Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

3.  Prospects and challenges for clinical decision support in the era of big data.

Authors:  Issam El Naqa; Michael R Kosorok; Judy Jin; Michelle Mierzwa; Randall K Ten Haken
Journal:  JCO Clin Cancer Inform       Date:  2018-11-09

4.  Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models.

Authors:  D Kim; H-H Won; S Su; L Cheng; W Xu; N Hamad; J Uhm; V Gupta; J Kuruvilla; H A Messner; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2014-03-03       Impact factor: 5.483

Review 5.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

6.  Different competing risks models applied to data from the Australian Orthopaedic Association National Joint Replacement Registry.

Authors:  Marianne H Gillam; Amy Salter; Philip Ryan; Stephen E Graves
Journal:  Acta Orthop       Date:  2011-09-06       Impact factor: 3.717

7.  Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas.

Authors:  Shuangshuang Fu; Michael Wang; Ruosha Li; David R Lairson; Bo Zhao; Xianglin L Du
Journal:  Cancer Epidemiol       Date:  2018-12-06       Impact factor: 2.890

8.  Application of the Multiplicative-Additive Model in the Bone Marrow Transplantation Survival Data Including Competing Risks.

Authors:  Asieh Ashouri; Amirali Hamidieh; Mahmood Mahmoodi; Kazem Mohammad; Molouk Hadjibabaie; Hojjat Zeraati; Akram Karimi; Ardeshir Ghavamzadeh
Journal:  Iran J Public Health       Date:  2015-04       Impact factor: 1.429

9.  The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study.

Authors:  José Luño; Javier Varas; Rosa Ramos; Ignacio Merello; Pedro Aljama; Alejandro MartinMalo; Julio Pascual; Manuel Praga
Journal:  Kidney Int Rep       Date:  2017-03-07

10.  Comparison of competing risks models based on cumulative incidence function in analyzing time to cardiovascular diseases.

Authors:  Minoo Dianatkhah; Mehdi Rahgozar; Mohammad Talaei; Masoud Karimloua; Masoumeh Sadeghi; Shahram Oveisgharan; Nizal Sarrafzadegan
Journal:  ARYA Atheroscler       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.